Nov 24, 2025 08:30AM
Aug 29, 2025 08:30AM
Aug 18, 2025 04:15PM
Aug 18, 2025 04:15PM
Aug 7, 2025 04:01PM
Jul 15, 2025 07:31AM
Jul 15, 2025 07:30AM Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer
Jul 14, 2025 07:30AM
Jul 14, 2025 07:30AM
Jul 10, 2025 04:01PM
Jun 10, 2025 08:45AM
Jun 2, 2025 09:30AM
Jun 2, 2025 09:29AM
May 22, 2025 05:32PM Iovance Biotherapeutics (IOVA) announces results of Amtagvi to be presented at ASCO 2025
May 22, 2025 05:31PM
May 8, 2025 04:01PM
May 2, 2025 04:01PM
Apr 23, 2025 04:15PM
Apr 18, 2025 05:30PM
Mar 28, 2025 04:30PM
Mar 21, 2025 05:15PM Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Feb 27, 2025 04:01PM
Feb 21, 2025 05:15PM
Feb 18, 2025 04:01PM
Feb 12, 2025 05:30PM
Feb 10, 2025 07:00AM
Feb 10, 2025 07:00AM
Jan 17, 2025 05:00PM Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Dec 20, 2024 05:00PM
Nov 26, 2024 04:02PM
Nov 26, 2024 04:01PM
Nov 7, 2024 04:01PM
Oct 31, 2024 04:01PM
Sep 3, 2024 05:00PM
Aug 16, 2024 05:00PM Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Aug 8, 2024 04:01PM
Jul 29, 2024 04:01PM
Jul 19, 2024 05:00PM
Jun 28, 2024 07:17AM
Jun 28, 2024 07:01AM
Jun 28, 2024 07:00AM
Jun 28, 2024 07:00AM Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
Jun 21, 2024 05:00PM
May 24, 2024 04:01PM
May 23, 2024 05:00PM
May 17, 2024 05:15PM
May 9, 2024 04:01PM
May 1, 2024 06:01AM
Apr 30, 2024 06:01AM Iovance Biotherapeutics to Present at Upcoming Conferences
Apr 24, 2024 04:01PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All